Compare Eli Lilly And Co (LLY) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Seagate Technology Holdings PLC — how do they compare? Eli Lilly And Co trades at $1,177.57 (market cap $1.04T), while Seagate Technology Holdings PLC trades at $780.38 (market cap $176.19B). The key difference: Eli Lilly And Co is far larger — about 5.9× Seagate Technology Holdings PLC's market cap, and Eli Lilly And Co pays the higher dividend (0.59%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Seagate Technology Holdings PLC for 41 Days on average.
| LLY | STX | |
|---|---|---|
Market Cap | $1.04T | $176.19B |
Volume | 3,064,878 | 5,061,875 |
Sector | Health | Technology |
52-Week High | $1.28K | $1.09K |
52-Week Low | $799.57 | $211.63 |
Typical Hold Time | 93 Days | 41 Days |
Enterprise Value | $1.09T | $178.34B |
Dividend Yield | 0.59% | 0.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,179.27, down 0.79% on the day, with a bullish technical outlook and strong fundamental momentum. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 expectation. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing its market leadership.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include competitive pressures in the obesity drug market and execution challenges in scaling production. With a consensus price target of $1,350, representing ~14% upside, the stock offers growth potential but requires monitoring of pipeline progress and market dynamics.
STX trades at $783, down 3.01% amid concerns about increased competition from Toshiba's planned HDD production expansion. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $5.71 vs. $5.10, and robust profitability metrics including 26.11% net income margin. Technical indicators are bearish with price near pivot point support at $782, while analyst consensus remains positive with 54% buy ratings and $1,130 price target.
Despite near-term competitive pressures, STX maintains strong AI-driven storage demand positioning. Investment opportunity lies in the company's record margins and nearly sold-out capacity, though risks include potential pricing pressure from increased industry supply and high valuation multiples that may limit upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
